Perspectives on anthracyclines plus ifosfamide in advanced soft tissue sarcomas.

Abstract

Doxorubicin and ifosfamide are currently the two main drugs for the treatment of soft tissue sarcomas in adults. Given in combination at full doses, with or without dacarbazine, these agents have induced higher response rates than were obtained with single-agent therapy. Because they involve considerable myelotoxicity, however, full-dose regimens should be… (More)

Topics

Cite this paper

@article{Casali1993PerspectivesOA, title={Perspectives on anthracyclines plus ifosfamide in advanced soft tissue sarcomas.}, author={P G Casali and Ugo Pastorino and Alberto Azzarelli and Rossella Bertulli and Patrizia Zucchinelli and Lilli Devizzi and Antonio Santoro}, journal={Cancer chemotherapy and pharmacology}, year={1993}, volume={31 Suppl 2}, pages={S228-32} }